Promethera Biosciences Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Poxel, Novartis and Allergan.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. |  Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | |
Founding Date | Founding Date 2002 | Founding Date 2009 | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more |
Employees | Employees 58321% increase | Employees 6 | Employees 75,883 | Employees 10,5471% decrease |
Valuation ($) | Valuation ($) 794.7 m | Valuation ($) 18.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $984k (FY, 2022) | Cost of goods €2.8m (FY, 2024) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit €3.8m (FY, 2024) | Gross profit $49.8b (FY, 2025) | Gross profit N/A |
Net income | Net income $221.8m (FY, 2022) | Net income (€18.3m) (FY, 2024) | Net income $14b (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 33.8m | Total funding raised $ 6.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Poxel
HQ
Lyon, FR
Employees
6
Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company